A study on the mechanism by which metformin-induced ferroptosis inhibits the proliferation of breast cancer cells found that metformin can increase intracellular Fe2+ and lipid ROS levels, and can also induce ferroptosis in breast cancer cells by up-regulating miR-324-3p to inhibit GPX4 expression. Here, GPX4 is linked to breast carcinoma.